Lv1
70 积分 2022-10-11 加入
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
1年前
已完结
Interferon alpha-2b in comprehensive treatment of patients with COVID-19
1年前
已完结
Efficacy of Interferon-Based Therapy for COVID-19: A Systematic Review and Meta-Analysis
1年前
已完结
[COMPARISON OF DIFFERENT TREATMENT REGIMENS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE]
1年前
已完结
Comparison of Effect of Telmisartan and Weight Reduction on Histological Activity of Nonalcoholic Steatohepatitis: A One Year Randomised Control Trial
1年前
已完结
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
1年前
已关闭
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
1年前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
1年前
已完结
皖公网安备34019202002308
